Acomplia - order Acomplia online

RSS Feed Homepage

FDA Panel Focuses of Suicidality at Hearing on Diet Drug Rimonabant
2007-06-15 20:11:00
We offer the lowest prices on all medications. If you find a retail website that offers a less expensive price, we will match their price AND give you an additional 5% off! Now click here and order the wonder pill, to obtain your dream weight. Only one click away!!! 100% proved and guaranteed results! 24/7 Live Chat, & Email Replies Within 24 hoursWe are here to answer your questions, and guarantee you will receive a response within 24 hours by email. For instant support, we offer 24/7 Live Chat!The make-or-break FDA advisory panel meeting on rimonabant (Acomplia / Zimulti) got underway on June 13th with a presentation on how independent experts attempted to sort-out and evaluate incidents of "suicidality" that occurred among participants in the clinical trials of the diet drug.Dr. Eric Coleman, FDA deputy director, said at the outset of the day-long hearing that the relationship between rimonabant, depression and suicide has been "a big concern for us."Dr. Kelly Posner of the N...
More About: Diet , Panel , Drug , Rimonabant , Hearing

Precautions for Acomplia Rimonabant Use
2007-05-31 00:03:00
Click here to place your order at our online pharmacy and furfill your dream of having the perfect body! You can be assured you will get the best possible service. We offer fast shipping, secured shopping cart, dedicated customer support and more!Depression and obesity are interrelated in some cases hence Acomplia Rimonabant should not be taken by patients with uncontrolled psychiatric illness such as depression disorders. It is recommended that psychotherapy be initiated first and then only therapy with Acomplia Rimonabant be considered after the psychiatric condition is controlled.As Acomplia Rimonabant is metabolised by the liver, it is advised to be cautious in patients with moderate hepatic impairment. Acomplia Rimonabant is not advised for patients with severe renal impairment. Acomplia Rimonabant should be used with caution in this population as the efficacy and safety of Acomplia Rimonabant treatment in patients over 75 years of age has not been sufficiently studied. Acomp...
More About: Mona

Acomplia Rimonabant ? FDA Review
2007-05-31 00:01:00
Click here to place your order at our online pharmacy and furfill your dream of having the perfect body! You can be assured you will get the best possible service. We offer fast shipping, secured shopping cart, dedicated customer support and more!After passing the two distinct clinical trials, Acomplia (Rimonabant ) is looking at the FDA for its review, who is in need of the two years complete data prior to release the approval of Acomplia Rimonabant as a diet drug. On the contrary in another clinical trial with patients treated both with Acomplia Rimonabant and Placebo, the former has shown some ill-effects like depression, mood swings with about 2.7 folds higher rate as compared the patients treated with Placebo. FDA now is still considering the release of approval of Acomplia Rimonabant.
More About: Review , Mona

Acomplia Rimonabant A New Class of Drug
2007-05-31 00:00:00
Click here to place your order at our online pharmacy and furfill your dream of having the perfect body! You can be assured you will get the best possible service. We offer fast shipping, secured shopping cart, dedicated customer support and more!In accordance with the report placed in the annual meeting of Endocrine Society at New Orleans, a demonstration in the Phase III multi-center clinical trial has shown that an entirely new class of drug, which is basically a selective endocannabinoid receptor antagonist (CB1), has been developed to treat obesity most effectively. Rimonabant ? under the brand Acomplia falls within this new class and works with high effectiveness by blocking the receptors in the Hypothalamus, which gets bound with the cannabinoid molecules, thereby curbing the urge to eat and simultaneously stops the crave for smoking.In the Phase III clinical trials, Acomplia Rimonabant has been tested with above 6000 obese persons (both males and females) in America and Euro...
More About: Drug , Class , Mona

What is Acomplia Rimonabant?
2007-05-30 23:58:00
Acomplia Rimonabant is a CB1 blocker. It offers solution to improve a variety of cardiometabolic risk factors in obese and overweight people. These risk factors include high LDL cholesterol levels, hypertension and diabetes and other factors being investigated as insulin resistance, low HDL cholesterol, and high triglyceride levels. Acomplia Rimonabant comes in the form of 20mg pill to be taken daily. CB1 receptors are found in the brain and in the peripheral organs and are part of the endocannabinoid system which is believed to play an important role in regulating body weight and controlling energy balance.Acomplia Rimonabant blocks CB1 receptors and thus decreases the hyperactivity of the endocannabinoids system resulting in less intake of food which in turn leads to weight loss.Based on the data available from various clinical trials, Acomplia Rimonabant is an extremely safe medication with minor side effects such as nausea, mood swings, anxiety and dizziness. However Acomplia ...
More About: Acomplia , Mona

Acomplia information about
2007-05-30 23:57:00
Click here to place your order at our online pharmacy and furfill your dream of having the perfect body! You can be assured you will get the best possible service. We offer fast shipping, secured shopping cart, dedicated customer support and more!buy acompliaacomplia discussion boardsacomplia rimonabantacomplia forumsorder acomplia rimonabantacomplia and fdatype 2 diabetes weight loss medication acompliaacomplia ukacomplia blogacomplia rimonabant labellingrimonabant acompliapaxil interactions acompliaacomplia side effectsAcomplia RimonabantAcomplia Rimonabant is on the wish list of millions people worldwide as a cure to stubborn obesity and the quickest as well as most effective solution to remove loads of unwanted fat.
More About: Information , Form , Format